Table 1.
Clinical characteristics of patients with carbapenem-resistant K. pneumoniae bacteremia.
| Demographics | Prior antibiotic exposure | ||
|---|---|---|---|
| Age (mean ± SD), years | 61.9 ± 16.6 | Carbapenem | 24 (100.0) |
| Gender, male | 19(79.2) | cephalosporin | 3 (12.5) |
| Length of stay (mean ± SD), days | 27.5 ± 16.5 | β-lactam and β-lactamase inhibitor | 11(45.8) |
| Underlying disease | Fluoroquinolone | 9 (37.5) | |
| Diabetes mellitus | 8(33.3) | Aminoglycoside | 8 (33.3) |
| Hypertension | 7(29.2) | Tigecycline | 11 (45.8) |
| Invasive procedures and devices | Glycopeptide | 14(58.3) | |
| Central venous catheter | 13(54.2) | Clinical outcomes | |
| Urinary catheter | 14(58.3) | Septic shock | 10(41.7) |
| Endotracheal tube | 17(70.8) | 30-day Mortality | 16(66.7) |
| Mechanical ventilation | 17(70.8) | ||
| Surgical drainage | 11(45.8) | ||
| Tracheostomy | 5(20.8) | ||
| Surgery | 16(66.67) | ||